OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer -

NCT03750175 · clinicaltrials.gov ↗

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Metastatic
Circulating Tumor DNA
KRAS Gene Mutation
NRAS Gene Mutation
BRAF Gene Mutation
Epidermal Growth Factor Receptor Inhibitor

Interventions

OTHER: Plasma circulating DNA analysis

Sponsor

Karen-Lise Garm Spindler